Polyrizon (PLRZ) Shares Outstanding (2023 - 2025)
Polyrizon's (PLRZ) quarterly Shares Outstanding (Entity) came in at $680380.0 in Q4 2025, up 34021.36% YoY from N/an in Q4 2024, and up 182.86% on a QoQ basis from $240535.0 in Q2 2025.
Polyrizon (PLRZ) Shares Outstanding (2023 - 2025) Analysis & Trends
Polyrizon (PLRZ) has 3 years of Shares Outstanding (Entity) data on file, last reported at $680380.0 in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 34021.36% year-over-year to $680380.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $680380.0 (up 34021.36% YoY) and the FY2025 annual result came in at $680380.0, up 34021.36% from the prior year.
- Shares Outstanding (Entity) improved to $680380.0 in Q4 2025, from $240535.0 in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $680380.0 in Q4 2025 to a low of $1354.0 in Q4 2023.
- A 3-year average of $231065.8 and a median of $121264.5 in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) surged 47.27% — and 2025, when it soared 34021.36%.
- Tracing PLRZ's Shares Outstanding (Entity) over 3 years: stood at $1354.0 in 2023, then surged by 47.27% to $1994.0 in 2024, then soared by 34021.36% to $680380.0 in 2025.
- The last three Shares Outstanding (Entity) figures came in at $680380.0 (Q4 2025), $240535.0 (Q2 2025), and $1994.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Polyrizon | 7.27 Mn | -4.22 Mn | - | 680,380.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 680,380.00 |
| Jun 30, 2025 | 240,535.00 |
| Dec 31, 2024 | 1,994.00 |
| Dec 31, 2023 | 1,354.00 |